Local government intervention slows pharm-emerging economies

05/2/2011 | PharmExec.com

In Turkey and other emerging pharmaceutical markets, governments are taking steps to bolster domestic production, such as by subjecting foreign-made drugs to separate certification inspections that slow the flow of imports, Pharmaceutical Executive magazine editor-in-chief William Looney writes. The average time for a new drug to get marketing approval in Turkey is 772 days, compared with about 200 days in the European Union, according to a trade association.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC